Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.18

+1.1%

Jan 2 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (191)	6/3/1998 4:13:00 PM
From: Anthony Wong	of 1722

Pfizer Gets Approval To Market Allergy Drug To Children Over Age Two June 03, 1998 11:42 AM NEW YORK -(Dow Jones)- Pfizer Inc. and UCB Pharma Inc. said Wednesday their Zyrtec allergy drug won Food and Drug Administration approval to be used in children two and older. The drug was initially approved for patients age 12 and older in January 1996 and was approved for children over six in September 1996. The company said Zyrtec is available in a one milligram per one milliliter banana-grape flavor syrup and in 5-mg and 10-mg tablets. Pfizer (PFE) and UCB Pharma co-promote Zyrtec in the U.S. UCB makets Zyrtec world-wide. UCB Pharma is a unit of UCB SA, a Belgium pharmaceuticals, chemicals and film company. Copyright (c) 1998 Dow Jones & Company, Inc. All Rights Reserved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next